J Cancer 2021; 12(24):7374-7379. doi:10.7150/jca.61905 This issue

Research Paper

Clinicalpathologic and Prognostic Significance of CGI-58 in Endometrial Cancer

Zhengzheng Shi, Xishao Luo, Hongqin Zhao, Baoyou Huang, Yuanqiu Wang, Xu Chen, Jiangtao Yu

Department of Gynecology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Shi Z, Luo X, Zhao H, Huang B, Wang Y, Chen X, Yu J. Clinicalpathologic and Prognostic Significance of CGI-58 in Endometrial Cancer. J Cancer 2021; 12(24):7374-7379. doi:10.7150/jca.61905. Available from https://www.jcancer.org/v12p7374.htm

File import instruction


Graphic abstract

Recent studies have reported that CGI-58 played an important role in carcinogenesis and tumoral progression in several cancers. In this study, we investigated the expression and prognostic value of CGI-58 in patients with endometrail cancer. Initially, the expression of CGI-58 was analyzed in 552 cases of endometrial carcinoma from The Cancer Genome Atlas (TCGA). Then, the mRNA level of CGI-58 from 32 normal endometrium and 40 endometrial cancer tissues was determined using real-time PCR. In addition, immunohistochemical staining of CGI-58 was performed in 140 endometrial specimens including 35 normal endometrial tissues, 25 atypical endometrial hyperplasia and 80 endometrial cancers. The expression of CGI-58 was significantly up-regulated in endometrial cancer tissues compared with normal endometrial tissue both in TCGA database and clinical cohorts. Over-expression of CGI-58 was significantly correlated with poor histological differentiation. Furthermore, high levels of CGI-58 expression were significantly associated with shorter overall survival for all analyzed cases. Our findings demonstrate that CGI-58 is up-regulated in endometrial cancer and high CGI-58 expression is a poor prognostic marker for endometrial cancer. CGI-58 may be a potential contributor to endometrial cancer oncogenesis and progression.

Keywords: CGI-58, Endometrial cancer, Immunohistochemistry, Prognosis